Biodesix, Inc. (BDSX) vs Insight Molecular Diagnostics Inc. (IMDX)
- Biodesix, Inc. BDSX 23.66 −4.25%
- Insight Molecular Diagnostics Inc. IMDX 3.01 −1.63%
Biodesix, Inc. and Insight Molecular Diagnostics Inc. are both Diagnostics & Research companies. Biodesix, Inc. is the larger, with a market value of $260.7M against $100.1M — 2.6× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 34.5% against −60.8%. Biodesix, Inc. has the higher net margin (−27.0% vs −2,955.6%) and the lower return on invested capital (−49.6% vs 0.00%). Across the 17 metrics below, Biodesix, Inc. leads on 12 and Insight Molecular Diagnostics Inc. on 5.
Valuation
Profitability
| Metric | BDSX | IMDX | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 82.50% | 48.32% | 50.89% |
| Operating margin | (20.02%) | (3,011.86%) | (8.57%) |
| Net margin | (26.97%) | (2,955.63%) | (6.37%) |
| Free cash flow margin | (19.82%) | (1,856.23%) | 0.00% |
| Return on equity | (540.01%) | 488.68% | (2.92%) |
| Return on assets | (30.33%) | (123.46%) | (6.71%) |
| Return on invested capital | (49.60%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack